Trials / Completed
CompletedNCT04048070
The Effect of Enhanced Recovery After Surgery in Endoscopic Sinus Surgery
Benefits of Enhanced Recovery After Surgery in Patients Undergoing Endoscopic Sinus Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- Beijing Tongren Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Enhanced recovery after surgery (ERAS) protocols have been widely applied during perioperative periods for different diseases, there are few reports of ERAS in patients undergoing endoscopic sinus surgery (ESS). This study therefore aimed to evaluate the benefits of ERAS protocol compared to traditional care following ESS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Flurbiprofen Axetil | One kind of NSAIDs, 200mg for 48 hours after surgery. |
| DRUG | Sufentanil | One kind of opioid drugs, 1.5μg/kg, and recorded the drug consumption after surgery |
| BEHAVIORAL | Extended perioperative counseling | The extended perioperative counseling contained additional information, including surgery procedures, importance of medicine treatment and medical help to relieve depression and anxiety about disease during peri-operation period. |
| BEHAVIORAL | Shorter fasting food and water time before surgery | The patients in ERAS group were required to fast food for 6 to 8 hours and provided 12.6% maltodextrin carbohydrate supplement beverage for 2 hours before surgery |
| BEHAVIORAL | Conventional perioperative counseling | THe conventional perioperative counseling included the risk of surgery and prognosis of disease and other things patients need to know. |
| BEHAVIORAL | Regular fasting food and water time before surgery | The stricter control of preoperative fasting requirements, prohibiting solids and liquids from previous midnight to operation time. |
Timeline
- Start date
- 2018-05-03
- Primary completion
- 2018-10-15
- Completion
- 2018-10-30
- First posted
- 2019-08-07
- Last updated
- 2019-08-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04048070. Inclusion in this directory is not an endorsement.